[1] YANG J H,LIN L K,ZHANG S.Epigenetic silencing of microRNA-335 contributes to nasopharyngeal carcinoma metastasis[J].Am J Otolaryngol,2020,41(1):102302.
[2] ZHANG Y,HUANG H,ZHANG Y,et al.Combined detection of serum miR-221-3p and miR-122-5p expression in diagnosis and prognosis of gastric cancer[J].J Gastric Cancer,2019,19(3):315-328.
[3] WU Q,REN X,ZHANG Y,et al.MiR-221-3p targets ARF4 and inhibits the proliferation and migration of epithelial ovarian cancer cells[J].Biochem Biophys Res Commun,2018,497(4):1162-1170.
[4] MILANI R,BROGNARA E,FABBRI E,et al.Targeting miR1555p and miR2213p by peptide nucleic acids induces caspase3 activation and apoptosis in temozolomideresistant T98G glioma cells[J].Int J oncol,2019,55(1):59-68.
[5] WANG M,JI Y Q,SONG Z B,et al.Knockdown of lncRNA ZFAS1 inhibits progression of nasopharyngeal carcinoma by sponging miR-135a[J].Neoplasma,2019,66(6):939-945.
[6] PETROZZA V,CARBONE A,BELLISSIMO T,et al.Oncogenic microRNAs characterization in clear cell renal cell carcinoma[J].Int J Mol Sci,2015,16(12):29219-29225.
[7] DONG Y,ZHANG N,ZHAO S,et al.MiR-221-3p and miR-15b-5p promote cell proliferation and invasion by targeting AXIN2 in liver cancer[J].Oncol Lett,2019,18(6):6491-6500.
[8] FAN F Y,DENG R,LAI S H,et al.Inhibition of microRNA-221-5p induces osteogenic differentiation by directly targeting smad3 in myeloma bone disease mesenchymal stem cells[J].Oncol Lett,2019,18(6):6536-6544.
[9] WANG X,LIAO X,HUANG K,et al.Clustered microRNAs hsa-miR-221-3p/hsa-miR-222-3p and their targeted genes might be prognostic predictors for hepatocellular carcinoma[J].J Cancer,2019,10(11):2520-2533.
[10] WU X,ZHOU C,ZHANG Y,et al.Cancer-derived exosomal miR-221-3p promotes angiogenesis by targeting THBS2 in cervical squamous cell carcinoma[J].Angiogenesis,2019,22(3):397-410.
[11] ZHOU C,MA J,HUANG L,et al.Cervical squamous cell carcinoma-secreted exosomal miR-221-3p promotes lymph angiogenesis and lymphatic metastasis by targeting VASH1[J].Oncogene,2019,38(8):1256-1268.
[12] LI H,ZHANG B,DING M,et al.C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3[J].Hepatol Int,2019,13(3):277-292.
[13] DENARO M,UGOLINI C,POMA A,et al.Differences in miRNA expression profiles between wild-type and mutated NIFTPs[J].Endocr Relat Cancer,2017,24(10):543-553.
[14] MIN K,LEE S K.EBV miR-BART10-3p promotes cell proliferation and migration by targeting DKK1[J].Int J Biol Sci,2019,15(3):657-667.
[15] LIU W,XIAO H,WU S,et al.MAP9 single nucleotide polymorphism rs1058992 is a risk of EBV-associated gastric carcinoma in Chinese population[J].Acta Virol,2018,62(4):435-440.
[16] 孙瑜宁,李迎喜,张恩东.肿瘤浸润炎症细胞在鼻咽癌中分布及预后相关性分析[J].现代医学,2020,48(2):172-179.
[17] SHI J,ZHANG Y,JIN N,et al.MicroRNA-221-3p plays an oncogenic role in gastric carcinoma by inhibiting PTEN expression[J].Oncol Res,2017,25(4):523-536.
[18] 张美婷,山顺林,耿炜.癌细胞放射抗拒性机制的研究进展[J].东南大学学报(医学版),2017,36(1):116-119.
[19] GARCÍA-DONAS J,BEUSELINCK B,INGLADA-PÉREZ L,et al.Deep sequencing reveals microRNAs predictive of antiangiogenic drug response[J].JCI Insight,2016,1(10):e86051. |